Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Topical Timolol on Post Acne Erythema
IRCT20190325043107N22Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of timolol in acne vulgaris and Postinflammatory erythema (PIE), sponsored by Tabriz University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
timolol
03
Conditions
acne vulgarisPostinflammatory erythema (PIE)
Beyond the preview
Go deeper on IRCT20190325043107N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N22.